Universe Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-06-30 |
|---|---|---|
Revenue | $9,152 | $12,884 |
Gross Profit | 3,164 | 3,244 |
EBITDA | -2,886 | -12,050 |
EBIT | -3,156 | -12,299 |
Net Income | -3,284 | -13,101 |
Net Change In Cash | 9,152 | 12,884 |
Free Cash Flow | 2,464 | -2,497 |
Cash | 47,272 | 8,861 |
Basic Shares | 3 | 6 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $23,024 | $23,024 | $32,308 | $40,143 |
Gross Profit | 6,071 | 6,071 | 10,315 | 21,891 |
EBITDA | -7,356 | -3,215 | -6,397 | |
EBIT | -7,842 | -8,019 | -3,723 | -6,931 |
Net Income | -8,727 | -8,727 | -6,163 | -8,736 |
Net Change In Cash | 23,024 | 23,024 | 32,308 | 40,143 |
Free Cash Flow | -9,869 | -9,869 | 1,075 | -1,406 |
Cash | 29,497 | 29,497 | 5,285 | 5,711 |
Basic Shares | 6 | 39 | 5 | 5 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$9.44 |
2025-03-31 | $0 |
2024-06-30 | $0 |
2022-12-31 | -$0.48 |
